3 Penny Stocks For Your July Watchlist
If you’re looking for the best penny stocks to buy in 2022, it all comes down to knowing where to look. While it may be complicated at first, understanding exactly what is going on in the stock market is crucial. Right now, the main aspects at play include climbing inflation, rising interest rates, and upcoming earnings reports.
All of this has made investing in penny stocks relatively difficult over the last few months. But, with increased volatility, there are also plenty of opportunities to make money with small caps right now. The best advice that investors always attempt to utilize is having a proper trading strategy.
This means knowing both your own tolerance for risk and how to use that as an advantage. So, while investing in penny stocks is not easy by any means, it can be a great way to make money in 2022. But, make sure that you have a consistent trading strategy that can adapt to the current state of the market. With this in mind, here are three penny stocks to watch in Mid-July 2022.
3 Penny Stocks to Watch in Mid-July 2022
- VEON Ltd. (NASDAQ: VEON)
- Powerbridge Technologies Co. Ltd. (NASDAQ: PBTS)
- Sonnet BioTherapeutics Holdings Inc. (NASDAQ: SONN)
VEON Ltd. (NASDAQ: VEON)
With over 4% in gains at EOD, VEON is a penny stock that many investors are watching right now. And as a result of its large movements during trading, it is worth taking a closer look at. In the past six months, we have seen over 65% in losses for VEON stock. And because of this, its recent bullish momentum is a welcomed advancement for investors to consider. To understand why shares are climbing, we have to take a look at its most recent news.
On July 11th, the company announced that its management has increased ownership in the company. This is a big deal and shows institutional and insider confidence in VEON right now. For some added context, VEON is a tech company that offers connectivity and internet services. The majority of this is in Europe, where it is a large service provider. So, with all of this in mind, does VEON deserve a spot on your penny stocks watchlist or not?
Powerbridge Technologies Co. Ltd. (NASDAQ: PBTS)
Another sizable gainer on July 15th is PBTS stock. By EOD, shares of PBTS had climbed by more than 3.5%. This comes after a five day uptick of more than 30%, which is quite substantial. So, why are we seeing shares of PBTS stock climb right now?
Well, it is tough to say as the company has not released any news recently. So, to try and understand this, we can look at its most recent announcement. Back in March, the company stated that its smart monitoring platform was included in the list of Zhuhai City innovative products. And, it stated that it would become the preferred choice for public procurement.
“Powerbridge has always been committed to providing platform applications and digital services covering smart ports, smart customs and digital cross-border trade for government agencies and enterprise customers. We have been offering our customers complete solutions, proposing a more efficient way of intelligent surveillance and operations and seamless inspection as well.”The President of Powerbridge, Stewart Lor
This was great news for the company and continues to be a major value add for investors. So, while it is impossible to say why shares are gaining ground right now, PBTS could be worth adding to your list of penny stocks to watch for the above reasons.
Sonnet BioTherapeutics Holdings Inc. (NASDAQ: SONN)
Sonnet BioTherapeutics is a penny stock that we have covered multiple times in the past few months. And with some small gains on July 15th and higher than average volume, it is worth covering once again. In the past month, SONN stock has shot up by more than 20%, which is quite substantial. And, during that time, we have also seen some major bullish sentiment overall with biotech penny stocks. The most recent news from Sonnet came on June 9th when it announced positive results from its preclinical combination study of SON-1010 with anti-PD1 checkpoint inhibition.
“We are excited to see that the combination of SON-1010 with an anti-PD1 antibody yielded compelling data in this preclinical model. These data support our strategy of pairing SON-1010 with a checkpoint inhibitor, with the goal of developing an improved treatment option for cancer patients.”The CEO of Sonnet, Pankaj Mohan
This is exciting news for the company and again, highlights the bullish sentiment we have seen recently with biotech stocks. Whether this makes SONN worth buying or not however, is up to you.
Which Penny Stocks Are You Buying Right Now?
Finding penny stocks to buy in 2022 is not easy. But, by understanding exactly what is going on in the stock market, investors can have a much easier time taking advantage. Right now, we continue to see a sizable amount of volatility that is causing major market movement.
And while this can be a benefit to some, without a proper trading strategy, it can mean losses at a high rate. So, to avoid this, investors always need to know exactly what is going on in the stock market and what their trading strategy is. With this in mind, which penny stocks are on your buy list right now?